US Patent 7709525 Chroman-derived anti-androgens for treatment of androgen-mediated disorders

Patent 7709525 was granted and assigned to Wisconsin Alumni Research Foundation on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Wisconsin Alumni Research Foundation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7709525

Date of Patent

May 4, 2010

Patent Application Number

10789835

Date Filed

February 27, 2004

Patent Primary Examiner

‌

James D. Anderson

Patent abstract

Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7709525 Chroman-derived anti-androgens for treatment of androgen-mediated disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API